CD8A and myeloid sarcoma: Going forward, elucidating the complex cellular interplay that occurs during CNS-CD8 adoptive transfer, as well as the autoregulatory functions and temporal mechanics involved, will be critical for interrogating these cells' effectiveness as a potential immunotherapeutic for MS patients.